|
Market Closed -
Bombay S.E.
06:02:25 2026-10-15 EDT
|
5-day change | 1st Jan Change | ||
| 2,523.00 INR | -0.65% |
|
-0.46% | +2.11% |
| 08-03 | GSK India first-quarter profit rises on steady vaccine demand | RE |
| 08-03 | GlaxoSmithKline Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
ETFs positioned on GlaxoSmithKline Pharmaceuticals Limited
| Name | YTD change | Weight | AuM | |
|---|---|---|---|---|
| +10.65% | - | 67 M€ | ||
| +14.66% | - | 9,273 M€ | ||
| +10.50% | - | 27,154 M€ | ||
| -10.86% | - | 2,054 M€ | ||
| -.--% | 0.39% | 773 M€ | ||
| -22.56% | 0.09% | 108 M€ | ||
| +14.93% | 0.08% | 611 M€ | ||
| +8.60% | 0.07% | 380 M€ | ||
| +8.04% | 0.07% | 337 M€ | ||
| -11.38% | 0.07% | 2,692 M€ | ||
| -6.75% | 0.07% | 2,189 M€ | ||
| -13.06% | 0.05% | 5 M€ | ||
| +19.23% | 0.04% | 10 M€ | ||
| +14.13% | 0.03% | 223 M€ | ||
| -.--% | 0.02% | 7 M€ | ||
| +12.89% | 0.02% | 61 M€ | ||
| 0.00% | 0.02% | 77 M€ | ||
| +16.75% | 0.02% | 199 M€ | ||
| +31.08% | 0.02% | 592 M€ | ||
| +15.96% | 0.02% | 1,021 M€ | ||
| +23.70% | 0.02% | 150 M€ | ||
| +17.48% | 0.02% | 268 M€ | ||
| -.--% | 0.01% | 11 M€ | ||
| +9.31% | 0.01% | 12,827 M€ | ||
| +15.20% | 0.01% | 24 M€ | ||
| +16.72% | 0.01% | 117 M€ | ||
| +17.75% | 0.01% | 216 M€ | ||
| +8.24% | 0.01% | 3,667 M€ | ||
| +15.69% | 0.01% | 57 M€ | ||
| +13.86% | 0.01% | 2,339 M€ | ||
| +15.00% | 0.01% | 89 M€ | ||
| +10.25% | 0.01% | 535 M€ | ||
| +19.05% | 0.01% | 1,808 M€ | ||
| +14.11% | 0.01% | 189 M€ | ||
| +21.28% | 0.01% | 6,575 M€ | ||
| +12.25% | 0.01% | 3,276 M€ | ||
| +16.43% | 0.01% | 43,353 M€ | ||
| +14.54% | 0.01% | 1,403 M€ |
Employees
3,103
Sector
Pharmaceuticals
- Stock Market
- Stocks
- GLAXO Stock
- ETFs GlaxoSmithKline Pharmaceuticals Limited
Select your edition
All financial news and data tailored to specific country editions
















